Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 19% ± 3% | |
epithelial cell | 5 studies | 24% ± 5% | |
oligodendrocyte | 5 studies | 20% ± 2% | |
glutamatergic neuron | 4 studies | 39% ± 15% | |
GABAergic neuron | 3 studies | 39% ± 5% | |
astrocyte | 3 studies | 19% ± 2% | |
microglial cell | 3 studies | 19% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 2% | |
dendritic cell | 3 studies | 18% ± 4% | |
basal cell | 3 studies | 20% ± 4% | |
interneuron | 3 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 979.60 | 459 / 459 | 100% | 12.17 | 1118 / 1118 |
esophagus | 100% | 875.70 | 1445 / 1445 | 100% | 7.52 | 183 / 183 |
ovary | 100% | 913.23 | 180 / 180 | 100% | 8.60 | 430 / 430 |
brain | 100% | 808.61 | 2639 / 2642 | 100% | 11.00 | 705 / 705 |
lung | 100% | 969.47 | 578 / 578 | 100% | 8.03 | 1153 / 1155 |
prostate | 100% | 1287.51 | 245 / 245 | 100% | 16.72 | 501 / 502 |
stomach | 100% | 791.61 | 359 / 359 | 100% | 8.65 | 285 / 286 |
bladder | 100% | 1051.86 | 21 / 21 | 100% | 9.82 | 502 / 504 |
thymus | 100% | 1219.87 | 653 / 653 | 100% | 10.05 | 602 / 605 |
uterus | 100% | 987.04 | 170 / 170 | 99% | 8.42 | 455 / 459 |
intestine | 100% | 919.98 | 966 / 966 | 99% | 9.46 | 522 / 527 |
pancreas | 100% | 533.31 | 328 / 328 | 99% | 8.05 | 176 / 178 |
kidney | 100% | 954.56 | 89 / 89 | 99% | 7.09 | 889 / 901 |
adrenal gland | 100% | 985.72 | 258 / 258 | 98% | 6.35 | 226 / 230 |
liver | 100% | 579.18 | 226 / 226 | 96% | 4.96 | 390 / 406 |
skin | 100% | 826.89 | 1808 / 1809 | 94% | 8.74 | 444 / 472 |
adipose | 100% | 969.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 893.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.27 | 29 / 29 |
spleen | 100% | 1211.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.87 | 1 / 1 |
muscle | 100% | 628.13 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 593.14 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 3.65 | 56 / 80 |
peripheral blood | 69% | 615.58 | 638 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042780 | Biological process | tRNA 3'-end processing |
GO_0001680 | Biological process | tRNA 3'-terminal CCA addition |
GO_0106354 | Biological process | tRNA surveillance |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_1990180 | Biological process | mitochondrial tRNA 3'-end processing |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0004810 | Molecular function | CCA tRNA nucleotidyltransferase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0160016 | Molecular function | CCACCA tRNA nucleotidyltransferase activity |
GO_0000049 | Molecular function | tRNA binding |
GO_0034062 | Molecular function | 5'-3' RNA polymerase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | TRNT1 |
Protein name | tRNA nucleotidyl transferase 1 CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase) |
Synonyms | CGI-47 |
Description | FUNCTION: Nucleotidyltransferase that catalyzes the addition and repair of the essential 3'-terminal CCA sequence in tRNAs, which is necessary for the attachment of amino acids to the 3' terminus of tRNA molecules, using CTP and ATP as substrates . tRNA 3'-terminal CCA addition is required both for tRNA processing and repair . Promotes tRNA repair and recycling downstream of the ribosome-associated quality control (RQC) pathway by mediating addition of the tRNA 3'-terminal CCA following cleavage by ANKZF1 and repair by ELAC1 . Also involved in tRNA surveillance by mediating tandem CCA addition to generate a CCACCA at the 3' terminus of unstable tRNAs and tRNA-like transcripts . While stable tRNAs receive only 3'-terminal CCA, unstable tRNAs beginning with GG are marked with CCACCA and rapidly degraded . The structural flexibility of RNA controls the choice between CCA versus CCACCA addition: following the first CCA addition cycle, nucleotide-binding to the active site triggers a clockwise screw motion, producing torque on the RNA . This ejects stable RNAs, whereas unstable RNAs are refolded while bound to the enzyme and subjected to a second CCA catalytic cycle . .; FUNCTION: [Isoform 2]: Adds 2 C residues (CC-) to the 3' terminus of tRNA molecules instead of a complete CCA end as isoform 1 does (in vitro). . |
Accessions | A0A494C1D4 ENST00000698410.1 A0A494BZV5 A0A8V8TN57 ENST00000698414.1 ENST00000280591.10 [Q96Q11-2] ENST00000339437.11 [Q96Q11-3] ENST00000651093.1 C9JRS7 A0A494C181 A0A494C1P4 ENST00000651352.1 ENST00000251607.11 [Q96Q11-1] ENST00000397779.3 ENST00000650839.1 A0A494C1L4 ENST00000465998.2 ENST00000650755.1 ENST00000698411.1 A0A494C0N8 ENST00000652340.1 A0A494C0A0 ENST00000434583.5 [Q96Q11-1] Q96Q11 ENST00000651316.1 ENST00000698413.1 ENST00000420393.5 [Q96Q11-3] A0A494C0Y2 F8W8C3 ENST00000698406.1 [Q96Q11-1] ENST00000650814.1 A0A8V8TM71 ENST00000402675.5 [Q96Q11-3] ENST00000698408.1 [Q96Q11-1] ENST00000413000.1 ENST00000698412.1 [Q96Q11-1] ENST00000651591.1 |